Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1035774Generated: October 25, 2026

Ethanol → 1-{6-[(6-Ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea

https://huagongshe.com/reaction/1035774

Reaction equation

Participants

RoleNameHCIDCharge
ReactantEthanolHCID 702—
Reactant1,4-Dimercapto-2,3-butanediolHCID 19001—
ReactantHCID 67524522HCID 67524522—
Reactant1-(2-Morpholin-4-ylethyl)-3-(6-sulphanyl-1,3-benzothiazol-2-yl)ureaHCID 86647876—
CatalystMonobasic potassium phosphateHCID 516951—
SolventWaterHCID 962—
Product1-{6-[(6-Ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]ureaHCID 4259865846.8%

Reaction Steps

The 1-{6-[(6-ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea was prepared according to the method described in Example 17a, but using 613 mg of 1-[2-(morpholin-4-yl)ethyl]-3-(6-sulphanyl-1,3-benzothiazol-2-yl)urea, 20 cm3 of degassed ethanol, 7 mg of potassium dihydrogen phosphate in 0.2 cm3 of water, 699 mg of DL-dithiothreitol and 300 mg of 3-chloro-6-ethoxy[1,2,4]triazolo[4,3-b]pyridazine. 354 mg of 1-{6-[(6-ethoxy[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulphanyl]-1,3-benzothiazol-2-yl}-3-[2-(morpholin-4-yl)ethyl]urea are thus obtained in the form of a white powder, the characteristics of which are as follows:

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08546393B2
Source datasetuspto-grants-2013_10
ORD IDord-f60aa43616f44124a61ea2f015acbe2a
Source noteuspto-grants-2013_10